v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
At-the-Market Public Offering [Member]
Private Placement [Member]
Common Stock [Member]
Common Stock [Member]
At-the-Market Public Offering [Member]
Common Stock [Member]
Private Placement [Member]
Additional Paid in Capital [Member]
Additional Paid in Capital [Member]
At-the-Market Public Offering [Member]
Additional Paid in Capital [Member]
Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2024 $ 137,246     $ 40     $ 920,609     $ 47 $ (783,450)
Beginning balance, units at Dec. 31, 2024       40,468,141              
Issuance of common stock, net of issuance costs 135,367 $ 246   $ 36     135,331 $ 246      
Issuance of common stock, net of issuance costs, units       35,739,810 61,542            
Issuance of pre-funded warrants in public offering/private placement 52,590           52,590        
Issuance of common stock in private placement for payment of developmental milestone consideration 5,000     $ 1     4,999        
Issuance of common stock in private placement for payment of developmental milestone consideration, units       975,496              
Vesting of restricted stock, units       247,970              
Unrealized loss on available-for-sale securities (45)                 (45)  
Equity-based compensation expense 3,341           3,341        
Net loss (39,282)                   (39,282)
Ending balance at Mar. 31, 2025 294,463     $ 77     1,117,116     2 (822,732)
Ending balance, units at Mar. 31, 2025       77,492,959              
Beginning balance at Dec. 31, 2024 137,246     $ 40     920,609     47 (783,450)
Beginning balance, units at Dec. 31, 2024       40,468,141              
Unrealized loss on available-for-sale securities (85)                    
Net loss (78,762)                    
Ending balance at Jun. 30, 2025 258,291     $ 78     1,120,463     (38) (862,212)
Ending balance, units at Jun. 30, 2025       77,602,741              
Beginning balance at Mar. 31, 2025 294,463     $ 77     1,117,116     2 (822,732)
Beginning balance, units at Mar. 31, 2025       77,492,959              
Vesting of restricted stock, units       32,189              
Exercises of common stock options 6           6        
Exercises of common stock options, units       2,733              
Issuance of common stock under employee stock purchase plan 197     $ 1     196        
Issuance of common stock under employee stock purchase plan, units       74,860              
Unrealized loss on available-for-sale securities (40)                 (40)  
Equity-based compensation expense 3,145           3,145        
Net loss (39,480)                   (39,480)
Ending balance at Jun. 30, 2025 258,291     $ 78     1,120,463     (38) (862,212)
Ending balance, units at Jun. 30, 2025       77,602,741              
Beginning balance at Dec. 31, 2025 180,010     $ 79     1,137,654     52 (957,775)
Beginning balance, units at Dec. 31, 2025       78,967,888              
Issuance of common stock, net of issuance costs   11,927 $ 79,224   $ 2 $ 15   11,925 $ 79,209    
Issuance of common stock, net of issuance costs, units         1,937,623 14,973,257          
Issuance of pre-funded warrants in public offering/private placement 147,104           147,104        
Issuance of common stock in private placement for payment of developmental milestone consideration 7,500     $ 1     7,499        
Issuance of common stock in private placement for payment of developmental milestone consideration, units       1,316,899              
Vesting of restricted and performance stock units       $ 1     (1)        
Vesting of restricted and performance stock, units       1,193,931              
Exercises of common stock options 17           17        
Exercises of common stock options, units       5,122              
Unrealized loss on available-for-sale securities (65)                 (65)  
Equity-based compensation expense 5,152           5,152        
Net loss (56,737)                   (56,737)
Ending balance at Mar. 31, 2026 374,132     $ 98     1,388,559     (13) (1,014,512)
Ending balance, units at Mar. 31, 2026       98,394,720              
Beginning balance at Dec. 31, 2025 $ 180,010     $ 79     1,137,654     52 (957,775)
Beginning balance, units at Dec. 31, 2025       78,967,888              
Exercises of common stock options, units 14,011                    
Unrealized loss on available-for-sale securities $ (165)                    
Net loss (111,536)                    
Ending balance at Jun. 30, 2026 374,075     $ 105     1,443,394     (113) (1,069,311)
Ending balance, units at Jun. 30, 2026       105,125,366              
Beginning balance at Mar. 31, 2026 374,132     $ 98     1,388,559     (13) (1,014,512)
Beginning balance, units at Mar. 31, 2026       98,394,720              
Issuance of common stock, net of issuance costs   $ 48,874     $ 7     $ 48,867      
Issuance of common stock, net of issuance costs, units         6,578,364            
Vesting of restricted stock, units       65,198              
Exercises of common stock options 61           61        
Exercises of common stock options, units       8,889              
Issuance of common stock under employee stock purchase plan 291           291        
Issuance of common stock under employee stock purchase plan, units       78,195              
Unrealized loss on available-for-sale securities (100)                 (100)  
Equity-based compensation expense 5,616           5,616        
Net loss (54,799)                   (54,799)
Ending balance at Jun. 30, 2026 $ 374,075     $ 105     $ 1,443,394     $ (113) $ (1,069,311)
Ending balance, units at Jun. 30, 2026       105,125,366